{"log_id": 3989851908073791773, "direction": 0, "words_result_num": 33, "words_result": [{"probability": {"variance": 0, "average": 0.999513, "min": 0.998958}, "location": {"width": 246, "top": 157, "height": 38, "left": 244}, "words": "答率方面有显著差异("}, {"probability": {"variance": 0.005096, "average": 0.966289, "min": 0.672834}, "location": {"width": 588, "top": 167, "height": 46, "left": 479}, "words": "p<0.05)。PASI50、PASI75、PASI90的应答率均一致随"}, {"probability": {"variance": 2e-06, "average": 0.999231, "min": 0.994583}, "location": {"width": 807, "top": 205, "height": 56, "left": 244}, "words": "治疗时间延长而逐渐增加。治疗12周后试验组和对照组的PGA痊愈率分别为"}, {"probability": {"variance": 0.0002, "average": 0.994159, "min": 0.925357}, "location": {"width": 822, "top": 253, "height": 58, "left": 242}, "words": "79%和2.3%、两组间无显著差异(P>0.05);PGA几乎痊愈率分别为41.6%和"}, {"probability": {"variance": 0.001096, "average": 0.985514, "min": 0.851288}, "location": {"width": 821, "top": 301, "height": 59, "left": 242}, "words": "6.4%,两组间有显著性差异(P<0.05)。此外,两组在DLQI总评分改善、VAS"}, {"probability": {"variance": 0.000218, "average": 0.993679, "min": 0.936696}, "location": {"width": 795, "top": 349, "height": 59, "left": 236}, "words": "评分改善、SF-36评分改善方面均无显著差异。PP集分析结果与FAS集一致"}, {"probability": {"variance": 1e-06, "average": 0.999237, "min": 0.996058}, "location": {"width": 823, "top": 398, "height": 58, "left": 235}, "words": "国外原研品多项临床试验结果分析显示:相同剂量下,体重较轻患者的疗效更为"}, {"probability": {"variance": 1.6e-05, "average": 0.997912, "min": 0.978799}, "location": {"width": 824, "top": 447, "height": 57, "left": 233}, "words": "明显。这与本品国内临床试验中采用25mg,每周2次给药在中国银屑病患者(相"}, {"probability": {"variance": 4.6e-05, "average": 0.997549, "min": 0.967049}, "location": {"width": 524, "top": 494, "height": 48, "left": 232}, "words": "对于欧美人群体重较轻)中显示的有效性情况相似"}, {"probability": {"variance": 1e-06, "average": 0.99916, "min": 0.997282}, "location": {"width": 131, "top": 540, "height": 36, "left": 236}, "words": "【药理毒理】"}, {"probability": {"variance": 2e-06, "average": 0.998672, "min": 0.996193}, "location": {"width": 99, "top": 590, "height": 29, "left": 227}, "words": "药理作用"}, {"probability": {"variance": 0.020107, "average": 0.950478, "min": 0.37964}, "location": {"width": 781, "top": 631, "height": 70, "left": 270}, "words": "肿瘤坏死因子(TNF)是体内天然产生的细胞因,其参正常的炎症和免"}, {"probability": {"variance": 0.002178, "average": 0.981374, "min": 0.733316}, "location": {"width": 828, "top": 681, "height": 64, "left": 221}, "words": "疫反应。TNF在类风湿关节炎(RA),多关节型幼年特发性关节炎(JA)、银屑"}, {"probability": {"variance": 9.4e-05, "average": 0.996307, "min": 0.947586}, "location": {"width": 824, "top": 731, "height": 60, "left": 221}, "words": "病性关节炎(PsA)和强直性脊柱炎(AS)的炎症发展过程及所致的关节病变中"}, {"probability": {"variance": 0.011175, "average": 0.967763, "min": 0.495119}, "location": {"width": 807, "top": 774, "height": 66, "left": 219}, "words": "发挥重要的作用。此外,TNF在斑片状银屑病CPSO)的炎症过程中发挥作用"}, {"probability": {"variance": 0.000609, "average": 0.993742, "min": 0.87307}, "location": {"width": 580, "top": 823, "height": 57, "left": 217}, "words": "在上述患者的相关组织与体液中,TNF的水平明显升高"}, {"probability": {"variance": 0.00084, "average": 0.986164, "min": 0.909421}, "location": {"width": 245, "top": 876, "height": 37, "left": 267}, "words": "TNF有两类不同的受体"}, {"probability": {"variance": 0.000959, "average": 0.984999, "min": 0.892512}, "location": {"width": 405, "top": 888, "height": 44, "left": 634}, "words": "分别为55kD的蛋白(p55)和75kD的"}, {"probability": {"variance": 2e-06, "average": 0.998669, "min": 0.994001}, "location": {"width": 293, "top": 922, "height": 40, "left": 213}, "words": "蛋白(p75)。天然状态下受"}, {"probability": {"variance": 3e-06, "average": 0.9987, "min": 0.99351}, "location": {"width": 415, "top": 935, "height": 45, "left": 622}, "words": "可溶性的形式存在于细胞表面。TNF的"}, {"probability": {"variance": 0.001375, "average": 0.986157, "min": 0.852937}, "location": {"width": 552, "top": 969, "height": 49, "left": 210}, "words": "生物学活性依赖于与其中一个细胞表面受体结合"}, {"probability": {"variance": 0.008534, "average": 0.964905, "min": 0.494156}, "location": {"width": 779, "top": 1008, "height": 78, "left": 258}, "words": "重组人Ⅱ型肿瘤死因子受体抗体融合蛋白是p75TNP受体蛋白,可结合"}, {"probability": {"variance": 0.01541, "average": 0.958264, "min": 0.441362}, "location": {"width": 829, "top": 1061, "height": 65, "left": 208}, "words": "TNF分子,为可溶性土聚体。重组人Ⅱ型肿瘤坏死因子受体抗体融合蛋白抑"}, {"probability": {"variance": 0.027693, "average": 0.905461, "min": 0.353832}, "location": {"width": 802, "top": 1110, "height": 60, "left": 205}, "words": "制TNF-α和NB(淋巴毒LTa])与细胞表面TNFR的结合,使NE失活"}, {"probability": {"variance": 0.004288, "average": 0.977737, "min": 0.623803}, "location": {"width": 924, "top": 1152, "height": 97, "left": 203}, "words": "体外研究未检测到重组人ⅡI型肿瘤坏死因子受体抗体融合蛋白与Ta的复合"}, {"probability": {"variance": 1.5e-05, "average": 0.997712, "min": 0.985701}, "location": {"width": 908, "top": 1205, "height": 64, "left": 203}, "words": "物;无论有无补体存在,表达跨膜TNF(与重组人Ⅱ型肿瘤坏死因受体抗体"}, {"probability": {"variance": 1e-06, "average": 0.999004, "min": 0.997309}, "location": {"width": 387, "top": 1255, "height": 45, "left": 201}, "words": "融合蛋白结合)的细胞都不会被溶解"}, {"probability": {"variance": 0.021868, "average": 0.808172, "min": 0.660293}, "location": {"width": 171, "top": 1257, "height": 60, "left": 922}, "words": "影少"}, {"probability": {"variance": 0.000248, "average": 0.994594, "min": 0.911131}, "location": {"width": 777, "top": 1304, "height": 57, "left": 248}, "words": "重组人Ⅱ型肿瘤坏死因子受体抗体融合蛋白对由TNF诱发的或调节的生物"}, {"probability": {"variance": 0.004026, "average": 0.981775, "min": 0.640562}, "location": {"width": 828, "top": 1349, "height": 59, "left": 197}, "words": "学反应也有调节作用,包括淋巴细胞迁移所需的粘附分子(如E- selectin和细胞"}, {"probability": {"variance": 0.008732, "average": 0.970384, "min": 0.48148}, "location": {"width": 829, "top": 1397, "height": 58, "left": 194}, "words": "间粘附分子1(ICAM-1))、血清中细胞因子(如I6)和基质金属蛋白酶-3"}, {"probability": {"variance": 0.00032, "average": 0.993878, "min": 0.908153}, "location": {"width": 806, "top": 1445, "height": 57, "left": 214}, "words": "MMP-3或基质裂解素)的表达。研究显示重组人Ⅱ型肿瘤坏死因子受体抗体"}, {"probability": {"variance": 2e-06, "average": 0.999192, "min": 0.993079}, "location": {"width": 813, "top": 1492, "height": 59, "left": 191}, "words": "融合蛋白对包括胶原诱导的小鼠关节炎在内的几个炎症动物模型有生物学作用"}], "language": 3}